Shortened treatment regimens versus the standard regimen for drug-sensitive pulmonary tuberculosis

about

Shortened treatment regimens versus the standard regimen for drug-sensitive pulmonary tuberculosis

Item

http://www.wikidata.org/entity/Q57775011

description

im Januar 2018 veröffentlichter wissenschaftlicher Artikel

@de

scientific article

@en

wetenschappelijk artikel

@nl

наукова стаття, опублікована в січні 2018

@uk

name

Shortened treatment regimens v ...... nsitive pulmonary tuberculosis

@en

Shortened treatment regimens v ...... nsitive pulmonary tuberculosis

@nl

type

Item

label

Shortened treatment regimens v ...... nsitive pulmonary tuberculosis

@en

Shortened treatment regimens v ...... nsitive pulmonary tuberculosis

@nl

prefLabel

Shortened treatment regimens v ...... nsitive pulmonary tuberculosis

@en

Shortened treatment regimens v ...... nsitive pulmonary tuberculosis

@nl

P1476

Shortened treatment regimens v ...... nsitive pulmonary tuberculosis

@en

P2093

Abhenil Mittal

http://www.w3.org/2001/XMLSchema#string

Angeline G Grace

http://www.w3.org/2001/XMLSchema#string

Jaya P Tripathy

http://www.w3.org/2001/XMLSchema#string

Prathap Tharyan

http://www.w3.org/2001/XMLSchema#string

Richard Kirubakaran

http://www.w3.org/2001/XMLSchema#string

Siddharth Jain

http://www.w3.org/2001/XMLSchema#string

Srinath Satyanarayana

http://www.w3.org/2001/XMLSchema#string

P2860

OPC-67683, a nitro-dihydro-imidazooxazole derivative with promising action against tuberculosis in vitro and in mice

Fluoroquinolones for treating tuberculosis (presumed drug-sensitive)

Access to new medications for the treatment of drug-resistant tuberculosis: patient, provider and community perspectives

Cardiotoxicity of fluoroquinolones

Delamanid for multidrug-resistant pulmonary tuberculosis

Randomized clinical trial of thrice-weekly 4-month moxifloxacin or gatifloxacin containing regimens in the treatment of new sputum positive pulmonary tuberculosis patients

New anti-tuberculosis drugs and regimens: 2015 update

A diarylquinoline drug active on the ATP synthase of Mycobacterium tuberculosis

Discovery and development of SQ109: a new antitubercular drug with a novel mechanism of action.

Efficacy, safety and tolerability of linezolid containing regimens in treating MDR-TB and XDR-TB: systematic review and meta-analysis.

P31

scholarly article

P356

10.1002/14651858.CD012918

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

2018

http://www.w3.org/2001/XMLSchema#string

P577

2018-01-12T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P932

6491108

http://www.w3.org/2001/XMLSchema#string